A Single, Trusted Source for
Deep Intelligence
A single, trusted source for deep, continuously updated intelligence on the global life sciences ecosystem. Proscizen profiles over 45,000+ life sciences companies—from stealth innovators to established market leaders, service providers, and investors—capturing granular insights across 160+ structured data points in machine-readable formats. Our profiles are designed to support competitive intelligence, strategic planning, business development and vendor evaluation.
Reach the Right
Decision Makers
Identifying and reaching the right decision makers at the right time is critical in life sciences industry, where buying cycles are complex and decisions are influenced by multiple stakeholders. Our Contact Explorer enables organizations to identify, prioritize, and engage key decision makers, scientific influencers, and high-value prospects across the global life sciences ecosystem.
Our database includes over one million pharma and biotech decision makers, scientists, and high-priority prospects, along with 500,000+ decision makers across life sciences service providers, giving teams both breadth and depth of coverage.
Validated Data Assets
at Scale
Accessing accurate, validated, and decision-ready BioPharma data at scale is one of the biggest challenges. Critical datasets are fragmented, inconsistently structured, difficult to standardize, and expensive to maintain in-house.
Proscizen’s proprietary biopharma data assets address this challenge by delivering comprehensive, historically deep, and continuously refreshed intelligence across the full pharmaceutical value chain. Each dataset is curated by subject-matter experts, rigorously validated, and structured at granular, machine-readable levels—enabling faster analysis, reducing bias, strengthening deal assessment, and supporting more confident capital allocation and strategic planning.
Get the Gist.
Skip the Rest.
In a world overloaded with news, clarity matters more than speed. Proscizen's News & Insights is built to cut through the noise and deliver what truly matters to life sciences decision-makers.
Backed by powerful human intelligence, our analysts track, verify, contextualize, and interpret developments across pharma and biotech companies globally. Instead of flooding users with raw headlines, we extract the gist, assess the impact, and highlight the implications—so teams can act faster and smarter.
Our coverage goes beyond what has already happened. We identify upcoming clinical, regulatory, manufacturing, and commercial events, helping organizations prepare before opportunities or risks materialize.
Precision-Built
Intelligence
Every organization has unique questions, markets, and decision challenges—and no off-the-shelf dataset can fully address them.
Proscizen's Custom Data Build & Product Development service is designed for organizations that need precision-built intelligence, not generic data. Whether you are a pharma company, service provider, competitive intelligence platform, consulting firm, or financial institution, we design and build custom datasets, features, and intelligence products aligned exactly to your objectives.
Since 2008, we have supported multiple leading pharma competitive and business intelligence platforms—not just by enhancing existing data, but by helping conceptualize, build, and scale new intelligence products from scratch.
Data-Anchored
Strategy
Built on deep life sciences domain expertise and strengthened by Proscizen's proprietary pharma datasets, our advisory practice helps organizations convert complex data into clear strategy and measurable outcomes.
Since 2008, our centre of excellence has supported Commercial, Business Development, Licensing, Strategy, Sales, and Competitive Intelligence teams across the global pharma ecosystem. We combine human expertise, structured intelligence, and advanced analytics to address real-world strategic, commercial, and investment challenges.
Unlike generic consulting firms, our advisory work is data-anchored, execution-focused, and tailored, ensuring decisions are backed by validated intelligence rather than assumptions.